Telehealth firms urge FDA to legalize peptides, with guardrails
Hims & Hers, which owns a peptide manufacturing facility in California, has said it plans to offer peptides if U.S. regulators legalize them.
Useful signal?
Sign in with GitHub below to react 👍 / 👎, or comment if a category looks wrong — your reactions help curate this feed. How feedback works